Gadoxetate for direct tumor therapy and tracking with real-time MRI-guided stereotactic body radiation therapy of the liver

Andrzej P. Wojcieszynski, Stephen A. Rosenberg, Jeffrey V. Brower, Craig R. Hullett, Mark W. Geurts, Zacariah E. Labby, Patrick M. Hill, R. Adam Bayliss, Bhudatt Paliwal, John E. Bayouth, Paul M. Harari, Michael F. Bassetti

Research output: Contribution to journalArticlepeer-review

56 Scopus citations

Abstract

SBRT is increasingly utilized in liver tumor treatment. MRI-guided RT allows for real-time MRI tracking during therapy. Liver tumors are often poorly visualized and most contrast agents are transient. Gadoxetate may allow for sustained tumor visualization. Here, we report on the first use of gadoxetate during real-time MRI-guided SBRT.

Original languageEnglish (US)
Pages (from-to)416-418
Number of pages3
JournalRadiotherapy and Oncology
Volume118
Issue number2
DOIs
StatePublished - Feb 1 2016
Externally publishedYes

Keywords

  • Guidance
  • Liver
  • MRI
  • Real-time
  • SBRT
  • Tracking

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Gadoxetate for direct tumor therapy and tracking with real-time MRI-guided stereotactic body radiation therapy of the liver'. Together they form a unique fingerprint.

Cite this